Figures
Abstract
Purpose
To assess the utility of fundus autofluorescence (FAF) patterns for predicting the EYS genotype in retinitis pigmentosa (RP) patients.
Methods
This retrospective, multi-institutional study analyzed FAF images from 200 RP patients (74 with EYS and 126 without EYS) from Singapore and Japan. Seven FAF patterns including the infinity sign and a broad banded hyper-autofluorescent leading edge were evaluated for their association with the EYS genotype.
Results
The infinity sign and broad banded hyperautofluorescent leading edge occurred more frequently in EYS eyes (p = 0.0014 and p = 0.036 respectively). Logistic regression analysis showed that the infinity sign was predictive of EYS (p = 0.003). The combined FAF parameters predicted EYS with a specificity of 95.20%, sensitivity of 25.68% and accuracy of 69.50%, with a cut-off value 0.5 based on the probability of seven FAF parameters.
Conclusions
In this multinational cohort study of patients with RP, we demonstrated that specific FAF patterns, particularly the infinity sign, have clinical utility in identifying patients with EYS-associated disease. These findings may be useful for clinicians and geneticists when genotyping patients with RP, and may also enhance our understanding of underlying pathophysiology of EYS-associated RP, which is a prevalent cause of RP in Asia and elsewhere.
Citation: Kominami T, Tan T-E, Ushida H, Jain K, Goto K, Bylstra YM, et al. (2025) Fundus autofluorescence features specific for EYS-associated retinitis pigmentosa. PLoS ONE 20(2): e0318857. https://doi.org/10.1371/journal.pone.0318857
Editor: Tatsuya Inoue, Yokohama City University, JAPAN
Received: November 21, 2024; Accepted: January 22, 2025; Published: February 19, 2025
Copyright: © 2025 Kominami et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data for this study are publicly available from the Nagoya University Institutional Repository (http://hdl.handle.net/2237/0002011889).
Funding: All the funding or resources of support for this study were the Japan Society for the Promotion of Science (JSPS) KAKENHI, grant number 23K15929 to TK; the SingHealth Foundation grant number R1748/71/2020 to BJF; and the SingHealth - Duke-NUS Institute of Precision Medicine grant numbers 05/FY2020/EX/06-A41 and 05/FY2022/EX(SLP)/69-A131(b) to KJ, YMB, and WKL. Funding organizations had no role in the design or conduct of this study. There was no additional external funding received for this study.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Retinitis pigmentosa (RP) is an inherited retinal dystrophy affecting approximately 1 in 4000 individuals globally [1–3]. RP typically presents with nyctalopia and peripheral vision loss secondary to rod photoreceptor degeneration, followed by loss of central vision secondary to cone photoreceptor loss [1]. Although the pathogenic genes of RP are highly diverse, pathogenic variants in the eyes shut homolog (EYS) gene are notably prevalent among East Asian populations, establishing EYS as a significant factor in RP’s genetic landscape [4–9].
Fundus autofluorescence (FAF) imaging, particularly in ultra-widefield (UWF) format, has been shown to be useful in the diagnosis and monitoring of RP [10] and in evaluating structure-function correlation [11,12]. FAF features such as parafoveal rings of high-density autofluorescence in patients with RP [13] and the genotype-phenotype correlation [14] were previously reported. There is a study to report that some FAF features are detected in patients with EYS-associated RP [15], but specific FAF features correlating with pathogenic EYS variants are not fully defined. More focused research is necessary especially to understand the FAF characteristics unique to EYS-associated RP, which could significantly impact diagnostic strategies and management in East Asian RP populations [4–6,8,9].
In this study, we aimed to evaluate the utility of fundus FAF features in predicting the presence of pathogenic EYS variants. By analyzing a comprehensive dataset from multiple institutions, we sought to enhance the specificity of FAF imaging for EYS-associated retinitis pigmentosa, potentially streamlining the pathway to appropriate genetic testing and therapeutic interventions. Our findings demonstrate the significant role of specific FAF features, particularly the so-called “infinity sign”, for the identification of EYS.
Methods
This was a retrospective, multi-institutional observational study to identify characteristic FAF features in patients with EYS gene variants associated with RP. We reviewed the medical charts of RP patients who visited the Department of Ophthalmology at Nagoya University Hospital or the Department of Medical Retina at the Singapore National Eye Centre between 2010 and 2023. Written informed consent was obtained for all patients. The protocol of this study was conformed to the tenets of the Declaration of Helsinki. The study received approval from the institutional review boards/ ethics committee of Nagoya University Hospital (study number 2020-0598) and Singapore National Eye Centre (study number R1748/71/2020). Patients with a history of ocular surgery, other retinal disease, or if the FAF images were of insufficient quality for analysis were excluded. Data were accessed on 15/May/2023 for Singapore data and on 29/Oct/2023 for Japan data. We had access to information that could identify individual participants during or after data collection but all patient identifiers were removed from the data set used for the study.
Patient demographics
We analyzed 200 FAF images from 200 eyes of patients diagnosed with RP sampled from the study centers. The study included RP cases of early-stage, late-stage, and cases with possible early cone dysfunction. The study cohort included 74 eyes with pathogenic EYS variants (EYS) and 126 eyes without pathogenic EYS variants (non-EYS). In Singapore, 24 eyes of EYS and 76 eyes of non-EYS were sequentially enrolled with a confirmed genetic diagnosis, while in Japan, patients were randomly selected, with 50 eyes in each category for balance. All participants were selected based on their genetic diagnosis, confirmed through comprehensive genomic testing. The proportion of EYS- and non-EYS-associated RP in the pooled cohort was 0.37 and 0.65, respectively, resulting in a Z-score of –5.2 and a study power of 99.9% for detecting differences between EYS- and non-EYS associated RP based on a two-proportion Z-test.
Fundus autofluorescence parameters
FAF imaging was performed using an ultra-wide field imaging device (Optos P200Tx; Optos, Dunfermline, UK). The presence of seven FAF parameters were evaluated (Fig 1): hyper autofluorescent (AF) crescent (Fig 1A), foveal hyper AF focus (Fig 1B), infinity sign (Fig 1C) which is characterized by nasal peripapillary and macula sparing resembling the shape of an infinity(∞) symbol, irregular sectoral areas of peripheral sparing (Fig 1D), broad-banded hyper AF leading edge (Fig 1E), inferior sectoral RP (Fig 1F), and a parafoveal hyper AF ring (Robson ring; Fig 1G). Four examiners (TK, TET, HU, and BJF) assessed the presence of the seven parameters in 200 FAF images with genotype masking at the time of grading. If each parameter was judged to be present in the image, a score of 2 was given; if it was judged not to be present, a score of 0 was given; if it was unclear whether it was present or not, a score of 1 was given. Inter-examiner variability of each parameter scored by four examiners was evaluated by the Fleiss’ kappa coefficient and parameters with non-negligible variability with Fleiss’ kappa coefficient lower than 0.2 were excluded from the analysis. For parameters that were judged not to have much inter-examiner variability with Fleiss’ kappa coefficient larger than 0.2, the scores of the four examiners were averaged, and a score of 1 or greater was judged to be positive, and a score less than 1 was judged to be negative.
This figure shows typical fundus autofluorescence (FAF) images for each of the diagnostic parameters used to evaluate EYS-associated retinitis pigmentosa. Each panel shows a unique feature characteristic of different retinal conditions: A: hyperautofluorescent crescent. B: focal foveal hyperautofluorescence. C: localized macular and peripapillary sparing (infinity sign). D: irregular sectoral areas of peripheral sparing. E: a broad banded hyper-autofluorescent leading edge. F: inferior sectoral retinitis pigmentosa. G: a parafoveal hyperautofluorescent ring (Robson ring). Arrowheads in each panel highlight the specific lesion areas.
Clinical outcomes
The primary outcome measure was the likelihood of occurrence of each features, in isolation or combination with other features, in eyes with and without EYS pathogenic variants. Secondary outcomes included the sensitivity, specificity, and accuracy of these features for predicting EYS group, and were calculated by incorporating a categorical variables for each parameter into a logistic regression model for statistical analysis. Receiver operating curve (ROC) and area under the curve were calculated by logistic regression model.
Statistical analysis
Inter-examiner variability was estimated using Fleiss kappa coefficients. Features with a kappa coefficient above 0.2 were included for further analysis. Differences in the presence of FAF features between EYS and non-EYS groups were assessed using Chi-square tests. Bonferroni correction was performed for multiple testing. Logistic regression was conducted to determine whether each feature, in isolation or in combination, was indicative of EYS or non-EYS groups. Sensitivity, specificity, and overall accuracy of the predictive model was calculated using a 2 x 2 contingency table, with a predefined cut-off value of 0.5. Python Scipy and Python Statsmodels were used for statistical analyses [16].
Results
Our analysis involved 200 FAF images from 200 patients with RP, carrying either pathogenic EYS variants (EYS) or other genetic variants (non-EYS). The ratio of Singaporeans and Japanese differed between EYS group and non-EYS group, but there were no significant differences in age or gender between the two groups (Table 1). The EYS group had significantly better best corrected visual acuity (BCVA) at the time of retinal imaging compared to the non-EYS group. A list of causative genes in the non-EYS group is shown in Table 2. The top five causative genes associated with RP in the non-EYS group were: USH2A, RP1, PRPH2, RHO and RPGR. The most common pathogenic variants for EYS were c.4957dupA and c.2528G > A in the Japanese cohort, while the Singapore cohort was enriched for EYS c.6416G > A. The distributions of EYS variants are shown in S1 Fig.
Inter-examiner variability and FAF feature reliability
Inter-examiner variability outcomes are shown in Table 3. Although there was some variation in the interquartile ranges, the medians were all 0. Irregular sectorial areas of peripheral sparing was the only parameter in which inter-examiner variability was not negligibly small and this feature was excluded from further analyses. Inter-examiner agreement for other FAF parameters indicated at least fair agreement (kappa ≥ 0.37), with consistent scoring among the four retina specialists who undertook the image evaluation.
Comparative analysis of EYS and non-EYS groups for FAF parameters
The presence of localized macular and peripapillary sparing on FAF, forming a so-called “infinity sign”, and a broad-banded hyper AF leading edge were over-represented in the EYS group compared to the non-EYS group, with chi square tests yielding p values of p = 0.0014 and p = 0.036 after Bonferroni correction, respectively (Fig 2). Pathogenic genes of cases who were judged with “infinity sign” were 3 cases with PRPH2, one case with RP1, one case with REEP6 and one case with USH2A, and those with a broad-banded hyper AF leading edges were 4 cases with PRPH2, one case with RHO, one case with RP1L1 and one cases with USH2A. EYS variants detected in cases with an infinity sign and a broad-banded hyperAF leading edge are shown in the S1 Table.
This figure shows a series of 2 × 2 contingency tables analyzing the relationship between various predictive indicators and EYS across different imaging features. A: hyperautofluorescent crescent, B: focal foveal hyperautofluorescence, C: localized macular and peripapillary sparing (infinity sign), D: inferior sectoral retinitis pigmentosa, E: a broad banded hyper-autofluorescent leading edge, F: a parafoveal hyperautofluorescent ring (Robson ring). Each table categorizes the outcomes into positive and negative predictions for EYS, with counts of true positives, false positives, true negatives, and false negatives listed. The rows represent the presence or absence of EYS pathogenic variants, and columns categorize the prediction outcomes. P-values calculated by the chi-square test to evaluate the difference between the EYS and non-EYS groups are shown under each parameter name.
Prediction of EYS-associated RP based on combinations of fundus autofluorescence features
The infinity sign exhibited the highest positive coefficient (beta 0.598, p = 0.003), indicating a strong predictive value for identifying EYS-associated RP (Table 4). Fig 3A shows the probability that an FAF image belonged to a patient with EYS-associated RP. This probability was calculated by substituting the presence or absence of each parameter into a logistic regression equation. A 2 × 2 contingency table with a cut-off value of 0.5 was then used to determine whether a case was EYS or non-EYS (Fig 3B). Sensitivity, specificity, and accuracy of the model was calculated as 25.68%, 95.24%, and 69.50%, respectively. The high specificity suggests that the model is effective at identifying true negatives, which is crucial for ruling out non-EYS RP in patients. The ROC curve created by combining FAF parameters was improved over the ROC curve created by using only visual acuity, age (at imaging and onset), and sex, with the AUC improving from 0.42 to 0.53 as shown in S2 Fig.
This figure illustrates the prediction results for EYS using logistic regression analysis. A displays shows swarm plots of probabilities calculated by the logistic regression equation, indicating the likelihood of EYS versus non-EYS. B shows a 2 × 2 contingency table where a cutoff value of 0.50 determines the prediction of EYS (0.50 or higher) versus non-EYS (less than 0.50). The table entries represent the counts of true positives (n = 19), true negatives (n = 120), false positives (n = 55), and false negatives (n = 6), indicating the performance of the predictive model.
Representative FAF images of patients with EYS-associated RP
Representative FAF images from patients with EYS-associated RP are shown in Fig 4. All FAF images were determined to have an infinity sign and broad banded hyper AF leading edge. A hyper-AF crescent was detected in the FAF images shown in Fig 4A, 4B and 4D.
This figure shows fundus autofluorescence images from different cases of individuals diagnosed with pathogenic EYS variants, highlighting the presence of specific autofluorescence patterns.
A: Japanese patient, 67-year-old female with a best corrected visual acuity (BCVA) of 0.1 (logMAR). Genetic variants c.2528G > A/c.6557G > A were detected. Positive for “ hyperautofluorescent crescent,” “infinity sign,” and “a broad banded hyper-autofluorescent leading edge.” B: Japanese patient, 45-year-old male with a BCVA of 0.0 (logMAR). Genetic variants c.4957dupA/c.8805C > A were detected. Features include “hyperautofluorescent crescent,” “infinity sign,” and “a broad banded hyper-autofluorescent leading edge.” C: Singaporean patient, 51-year-old male with a BCVA of 0.4 (logMAR). Genetic variants c.6416G > A/c.5086G > T. Positive for “infinity sign” and “a broad banded hyper-autofluorescent leading edge.” D: Singaporean patient, 60-year-old male with a BCVA of 0.0 (logMAR). Genetic variants c.6416G > A/c.904C > T. Displaying “hyperautofluorescent crescent,” “infinity sign,” and “a broad banded hyper-autofluorescent leading edge.” Each image captures the distinct autofluorescence characteristics associated with EYS, providing insights into the phenotypic expression related to specific genetic mutations.
Discussion
The present study revealed the distinct prevalence of specific FAF features in patients with EYS-associated RP. Notably, the so-called infinity sign and presence of a broad-banded hyperautofluorescent leading edge were significantly more prevalent among EYS-associated RP patients. This finding highlights the potential of these biomarkers in the initial screening of RP for EYS-associated genetic contributions. Logistic regression analysis also showed that the infinity sign is an important indicator for assessing the probability of EYS-associated disease. Although the sensitivity was relatively low, the high specificity of these parameters suggests that a positive identification of features such as the infinity sign robustly indicates the presence of EYS variants in patients with RP. These results may allow for more targeted genetic investigations and refine diagnostic protocols in clinical settings, particularly in cases where a single EYS allele is identified by genetic testing and additional testing may be warranted to identify a second EYS allele to complete a genotype.
The infinity sign and broad-banded hyperAF leading edge emerged as potent indicators for EYS-associated RP. A previous report identified a crescent-shaped hyperautofluorescent leading edge and perifoveal hyperAF rings in EYS-associated RP [15], but our study suggests that these signs are less associated with EYS than the infinity sign or the broad-banded leading edge, at least in our East Asian study cohort. The larger sample size in our study may have enabled a more accurate analysis, reinforcing the value of these novel biomarkers for the identification of EYS-associated RP. It is worth pointing out that previous studies of European and North American EYS cohorts also revealed the presence of FAF features identified in our study, including the infinity sign and broad-banded leading edge, albeit without mention of these features as a specific sign of EYS-associated RP [15,17,18]. Moreover, previous work from Japan indicated that the presence of nasal sparing on FAF was relatively prevalent among RP cases among Japanese patients [19], which may directly reflect the high prevalence of EYS-associated RP in Japan. In that work, the presence of nasal sparing was suggested to be the result of cone photoreceptor enrichment in both the macula and the nasal peripapillary retina [20], which we likewise speculate is the underlying mechanism for the peculiar patterns of FAF seen in EYS-associated RP. Furthermore, recent work suggests that EYS may protect against phototoxicity in diurnal animals/humans [21]. We might speculate that the irregular AF patterns observed in EYS-associated RP are related in part to areas of more intensive retinal light exposure.
It should be noted that among the eight PRPH2-associated RP cases included in this study, the “infinity sign” was observed in three cases, and a broad-banded AF leading edge was observed in four cases, both of which occurred relatively frequently although it remains difficult to determine whether these FAF features are characteristic of PRPH2-associated RP because of its limited number. They share these characteristic FAF findings possibly because both EYS, which is involved in the ciliary axoneme of photoreceptors and plays a pivotal role in the structural organization and maintenance of the outer segment (OS) [22], and PRPH2, which is essential for OS disc formation [23], both play important roles in preserving photoreceptor OS integrity. However, these two conditions have different inheritance patterns - EYS being Autosomal Recessive (AR) and PRPH2 typically being Autosomal Dominant (AD) [24]. In the presence of an AD pedigree, the FAF findings might point towards PRPH2, while in sporadic or AR cases, they would point more towards EYS. Therefore, FAF as a biomarker would still be useful for EYS.
Both the infinity sign and broad banded leading edge were found to be significantly associated with EYS-associated RP, although only the infinity sign was independently associated with EYS disease following logistic regression. We cannot exclude the possibility of an interaction between parameters with multicollinearity, wherein one parameter was judged to be insignificant because the effect of one parameter was nullified by another. FAF features may overlap, although it remains unclear what underlying pathophysiology is responsible for the clinical features observed here.
Our analysis confirmed that these specific FAF features effectively identified EYS-associated RP resulted with high specificity but low sensitivity and AUC. This shortcoming is important to note because these biomarkers markers will unlikely detect every case of EYS RP, but are highly specific when present. This robust specificity is especially valuable in clinical settings where accurate diagnosis can guide genetic counseling and tailor treatment strategies, potentially altering patient management. Furthermore, the establishment of an association between specific FAF features and specific EYS mutations could drive future research to explore automated image analysis techniques, further enhancing the efficiency and accuracy of diagnoses. Among the EYS variants observed in cases presenting with an “infinity sign” or a broad-banded hyperAF leading edge, c.2528G > A and c.4957dupA appeared relatively frequently, but these two variants are widely detected in general, and our current analysis did not detect a specific EYS variant significantly correlated with those FAF parameters.
Previous studies highlighted the utility of specific FAF patterns in diagnosing genetic subtypes of RP, associating characteristic autofluorescence features with specific genetic variants [14,25]. Conversely, PRPF8 was reported to show variable expressivity of FAF features [26], resulting in overlapping phenotypes even within the same pathogenic gene, complicating the diagnostic process. This variability might also apply to other RP pathogenic genes, explaining the lower sensitivity observed in applying every FAF parameter in this study. We also hypothesize that the presence of more typical generalized RP among many of the EYS cases in the current study may be related to the presence of more pathogenic EYS variants, with milder variants unmasking the various FAF patterns we observed as biomarkers for EYS disease.
Our study had several limitations, including the difficulty in identifying FAF parameters consistently because the agreement of examiners graders were mostly “moderate” at best judged by kappa values, the relatively low sensitivity of the FAF markers, which limits their utility in early disease detection and may delay interventions for some patients. Our study included patients with early stage RP, late-stage RP, and cases with possible early cone dysfunction. Although FAF patterns may differ depending on disease stage, we did not perform stage-specific evaluations in this analysis. Additionally, the retrospective design may introduce biases related to case selection and data interpretation. These limitations suggest areas for improvement, such as prospective studies and advanced imaging technologies to enhance early detection and diagnostic accuracy. Furthermore, while the study was multinational with patients from Japan and Singapore, a larger study that includes patients from additional geographic regions including Europe and the Americas would help to control for any genetic background effects that may influence the effect of EYS on FAF patterns in RP patients.
Despite these limitations, our focus on the correlation between specific FAF features and EYS gene mutations in RP is a significant strength. This specificity provides a foundation for more precise genetic and phenotypic profiling within this disease category. Additionally, the multicenter approach enhances the generalizability of the findings across different populations, demonstrating the relevance of this research in diverse clinical settings.
This study shows the diagnostic value of specific FAF features, notably the infinity sign and presence of a broad-banded leading edge, in identifying patients with EYS-associated RP. These features, while not universally present, appear to be highly specific and this is important in certain clinical settings, particularly in regions such as East Asia where EYS-associated RP is highly prevalent. Expanding this study to include more diverse patient populations and prospective designs may further validate and extend our findings. In conclusion, our study reveals the importance of specific autofluorescence markers in diagnosing EYS-associated RP, providing a useful tool for clinicians that may lead to improved patient outcomes through more precise and timely interventions in the future.
Declaration of Generative AI and AI-assisted technologies in the writing process
During the preparation, this work used ChatGPT (GPT-4 September 25 version) in order to generate only a preliminary draft of the manuscript of this study. All subsequent drafts, data collection, citations, and interpretations were done by human researchers. After using this tool, the authors reviewed and edited the content and take full responsibility for the content of the publication.
Supporting information
S1 Fig. Distribution of EYS Variants in Japanese and Singaporean Populations.
The bar chart shows the distribution of specific EYS gene variants identified in Japanese and Singaporean patient cohorts. The black bars represent the number of occurrences of each pathogenic variants in the Japanese cohort, while the gray bars represent the Singaporean cohort. Each bar corresponds to the number of times a specific variant or combination of variants was observed in the each population.
https://doi.org/10.1371/journal.pone.0318857.s001
(TIF)
S2 Fig. Receiver operating curve (ROC) Curves for Predicting EYS vs.
Non-EYS using Logistic Regression Models. S2 Fig shows the Receiver operating curve (ROC) curves comparing two logistic regression models for distinguishing between patients with EYS mutations and those without. The Full ROC curve (black line) represents the model using both the baseline parameters (age at imaging, age at onset, sex, Va) and additional fundus autofluorescence (FAF) parameters (crescent, foveal, infinity, broadband, robson, sectoral). The Base ROC curve (gray line) represents the model using only the baseline parameters. The area under the curve (AUC) for the Full ROC curve is 0.53, indicating a improved discriminative ability compared to the Base ROC curve, which has an AUC of 0.42.
https://doi.org/10.1371/journal.pone.0318857.s002
(TIF)
S1 Table. EYS variants detected in cases with infinity sign and a broad-banded hyper AF leading edge.
https://doi.org/10.1371/journal.pone.0318857.s003
(TIF)
References
- 1. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795–809. pmid:17113430
- 2. Pagon RA. Retinitis pigmentosa. Surv Ophthalmol. 1988;33(3):137–77. pmid:3068820
- 3. Verbakel SK, van Huet RAC, Boon CJF, den Hollander AI, Collin RWJ, Klaver CCW, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res. 2018;66:157–86. pmid:29597005
- 4. Chan CM, Tan TE, Jain K, Bylstra Y, Mathur RS, Tang RWC, et al. Retinitis pigmentosa associated with the EYS C2139Y variant: an important cause of blindness in East Asian populations. Retina. 2023;43(10):1788–96. pmid:37418643
- 5. Goto K, Koyanagi Y, Akiyama M, Murakami Y, Fukushima M, Fujiwara K, et al. Disease-specific variant interpretation highlighted the genetic findings in 2325 Japanese patients with retinitis pigmentosa and allied diseases. J Med Genet. 2024;61(7):613–20. pmid:38499336
- 6. Hosono K, Ishigami C, Takahashi M, Park DH, Hirami Y, Nakanishi H, et al. Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS One. 2012;7(2):e31036. pmid:22363543
- 7. Iwanami M, Oishi A, Ogino K, Seko Y, Nishida-Shimizu T, Yoshimura N, et al. Five major sequence variants and copy number variants in the EYS gene account for one-third of Japanese patients with autosomal recessive and simplex retinitis pigmentosa. Mol Vis. 2019;25:766–79pmid:31814702
- 8. Koyanagi Y, Akiyama M, Nishiguchi KM, Momozawa Y, Kamatani Y, Takata S, et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J Med Genet. 2019;56(10):662–70. pmid:31213501
- 9. Lee BJH, Tham YC, Tan TE, Bylstra Y, Lim WK, Jain K, et al. Characterizing the genotypic spectrum of retinitis pigmentosa in East Asian populations: a systematic review. Ophthalmic Genet. 2023;44(2):109–18. pmid:36856324
- 10. Dysli C, Schuerch K, Escher P, Wolf S, Zinkernagel MS. Fundus autofluorescence lifetime patterns in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2018;59(5):1769–78. pmid:29610860
- 11. Ogura S, Yasukawa T, Kato A, Usui H, Hirano Y, Yoshida M, et al. Wide-field fundus autofluorescence imaging to evaluate retinal function in patients with retinitis pigmentosa. Am J Ophthalmol. 2014;158(5):1093–8. pmid:25062603
- 12. Oishi A, Ogino K, Makiyama Y, Nakagawa S, Kurimoto M, Yoshimura N. Wide-field fundus autofluorescence imaging of retinitis pigmentosa. Ophthalmology. 2013;120(9):1827–34. pmid:23631947
- 13. Robson AG, Tufail A, Fitzke F, Bird Alan C, Moore AT, Holder GE, et al. Serial imaging and structure-function correlates of high-density rings of fundus autofluorescence in retinitis pigmentosa. Retina. 2011;31(8):1670–9. pmid:21394059
- 14. Hariri AH, Gui W, Datoo O’Keefe GA, Ip MS, Sadda SR, Gorin MB. Ultra-widefield fundus autofluorescence imaging of patients with retinitis pigmentosa: a standardized grading system in different genotypes. Ophthalmol Retina. 2018;2(7):735–45. pmid:31047384
- 15. Sengillo JD, Lee W, Nagasaki T, Schuerch K, Yannuzzi LA, Freund KB, et al. A distinct phenotype of Eyes shut homolog (EYS)-retinitis pigmentosa is associated with variants near the C-terminus. Am J Ophthalmol. 2018;190:99–112. pmid:29550188
- 16.
Skipper Seabold JP. Statsmodels: econometric and statistical modeling with python. Austin, Texas: Presented at: SciPy 2010; 2010.
- 17. Soares RM, Carvalho AL, Simão S, Soares CA, Raimundo M, Alves CH, et al. Eyes shut homolog-associated retinal degeneration: Natural history, genetic landscape, and phenotypic spectrum. Ophthalmol Retina. 2023;7(7):628–38. pmid:36764454
- 18. Mucciolo DP, Sodi A, Passerini L, Murro V, Cipollini F, Borg I, et al. Fundus phenotype in retinitis pigmentosa associated with EYS mutations. Ophthalmic Genet. 2018;39(5):589–602. pmid:30153090
- 19. Nakagawa S, Oishi A, Ogino K, Morooka S, Oishi M, Sugahara M, et al. Asymmetric cone distribution and its clinical appearance in retinitis pigmentosa. Retina. 2016;36(7):1340–4. pmid:26689273
- 20. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292(4):497–523. pmid:2324310
- 21. Otsuka Y, Imamura K, Oishi A, Asakawa K, Kondo T, Nakai R, et al. Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction. JCI Insight. 2024;9(8):e174179. pmid:38646933
- 22. Alfano G, Kruczek PM, Shah AZ, Kramarz B, Jeffery G, Zelhof AC, et al. EYS is a protein associated with the ciliary axoneme in rods and cones. PLoS One. 2016;11(11):e0166397. pmid:27846257
- 23. Loewen CJ, Moritz OL, Molday RS. Molecular characterization of peripherin-2 and rom-1 mutants responsible for digenic retinitis pigmentosa. J Biol Chem. 2001;276(25):22388–96. pmid:11297544
- 24. Kajiwara K, Hahn LB, Mukai S, Travis GH, Berson E L, Dryja TP. Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature. 1991;354(6353):480–3. pmid:1684223
- 25. Trichonas G, Traboulsi EI, Ehlers JP. Correlation of ultra-widefield fundus autofluorescence patterns with the underlyinggenotype in retinal dystrophies and retinitis pigmentosa. Ophthalmic Genet. 2017;38(4):320–4. pmid:27880076
- 26. Maubaret CG, Vaclavik V, Mukhopadhyay R, Waseem NH, Churchill A, Holder GE, et al. Autosomal dominant retinitis pigmentosa with intrafamilial variability and incomplete penetrance in two families carrying mutations in PRPF8. Invest Ophthalmol Vis Sci. 2011;52(13):9304–9. pmid:22039234